Dawah Pharmaceuticals is a U.S.-based pharmaceutical company that brings FDA-compliant sterile injectables and ophthalmic medicines to market through strategic partnerships with overseas contract manufacturers. With operations spanning the United States, Egypt, and the MENA region, it combines U.S. regulatory expertise with Egyptian manufacturing relationships, including joint ventures whose facilities produce more than 200 million units annually. Founded by Dr. Hossam Abdel Maksoud, whose healthcare experience dates to 1993, Dawah is building a pipeline of essential medicines aimed at addressing supply gaps in global healthcare.
FDA-compliant
compliance_program